Skip to main content
Clinical Trials/ISRCTN73295852
ISRCTN73295852
Completed
未知

ong-term neurocognitive assessment of children following an episode of severe malaria: the artesunate suppository trial cohort

Mahidol Oxford Tropical Medicine Research Unit (MORU) (Thailand)0 sites6,000 target enrollmentMay 28, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Mahidol Oxford Tropical Medicine Research Unit (MORU) (Thailand)
Enrollment
6000
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 28, 2013
End Date
March 1, 2017
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Mahidol Oxford Tropical Medicine Research Unit (MORU) (Thailand)

Eligibility Criteria

Inclusion Criteria

  • TQQ\+ questionnaire, socioeconomic status, clinical history, height on:
  • 1\. Surviving children originally enrolled in Study 13
  • 2\. Male or female
  • 3\. Written informed consent by legally acceptable representative (plus assent if appropriate)
  • 4\. Willingness and ability of the participants/guardians to comply with the study tests
  • Detailed neurocognitive exams
  • 1\. \~30% stratified sample of the surviving study cohort meeting criteria above
  • 2\. TQQ positive children
  • 3\. \>8 years of age
  • (Additional inclusion criteria will apply for participants who undergo EEG and/or MRI)

Exclusion Criteria

  • 1\. Signs of acute illness
  • Detailed neurocognitive exams
  • 1\. Signs of acute illness
  • 2\. Anti\-malarial injection at enrolment into Study 13
  • (Additional exclusion criteria will apply for participants who will undergo EEG and/or MRI)

Outcomes

Primary Outcomes

Not specified

Similar Trials